Similar articles

• Monoclonal antibodies in the diagnosis and treatment of malignant conditions.

  Allum WH, Macdonald F, Fielding JW. Allum WH, et al. Surg Annu. 1986;18:41-64. Surg Annu. 1986. PMID: 2417343 Review. No abstract available.
• [Diagnosis and treatment of colorectal cancer using monoclonal antibodies].

  Inagi H, Okuda H, Shimano T, Kadota T, Mori T. Inagi H, et al. Gan To Kagaku Ryoho. 1986 Jul;13(7):2291-7. Gan To Kagaku Ryoho. 1986. PMID: 3460528 Japanese.
• [The tumor-associated antigen CA 19-9 in the differential diagnosis and course control of malignancies of the pancreas and the gastrointestinal tract].

  Klapdor R, Greten H. Klapdor R, et al. Dtsch Med Wochenschr. 1984 Dec 14;109(50):1935-9. Dtsch Med Wochenschr. 1984. PMID: 6210188 German. No abstract available.
• [Evaluation of a monoclonal antibody (CA 19-9 system) in gastrointestinal disease--in comparison with CEA and IAP].

  Furukawa M, Kozaka S, Kushibiki K, Ashida Y, Saito H, Yamamoto H, Furukawa T. Furukawa M, et al. Nihon Gan Chiryo Gakkai Shi. 1985 Feb 20;20(1):25-30. Nihon Gan Chiryo Gakkai Shi. 1985. PMID: 3858395 Japanese. No abstract available.
• [Tumor markers in digestive oncology: present status of the topic and prospects for the future].

  Desaive C. Desaive C. Rev Med Liege. 1987 Nov 15;42(22):881-7. Rev Med Liege. 1987. PMID: 2447625 Review. French. No abstract available.